Jessica Tarn Dr Dennis Lendrem Dr Clare Lendrem Ben Hargreaves Professor Fai Ng et al. | Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life | 2022 |
|
Emmanuella Traianos Dr James Locke Dr Dennis Lendrem Ben Hargreaves Jessica Tarn et al. | Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome | 2020 |
|
Dr Kate Hackett Kristen Davies Jessica Tarn Ben Hargreaves Dr Dennis Lendrem et al. | Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome | 2019 |
|
Kundan Iqbal Dr Dennis Lendrem Ben Hargreaves Professor John Isaacs Dr Ben Thompson et al. | Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patients | 2019 |
|
Jessica Tarn Dr Nadia Howard-Tripp Dr Dennis Lendrem Andrew Skelton Dr Katherine James et al. | Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials | 2019 |
|
Dr Peter Gallagher Sheryl Mitchell Dr Bridget Griffiths Vicki Hindmarsh Ben Hargreaves et al. | Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren’s Syndrome – Capturing the discrepancy | 2017 |
|
Dr Arthur Pratt Dr Dennis Lendrem Ben Hargreaves Professor John Isaacs
| Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data | 2016 |
|
Dr Amy Anderson Dr Arthur Pratt Dr John Doran Christine Routledge Ben Hargreaves et al. | IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anti-citrullinated peptide antibody-negative rheumatoid arthritis | 2016 |
|
Dr Katie Hackett Dr Dennis Lendrem Ben Hargreaves Vicki Strassheim Dr Zoe Gotts et al. | Objective Improvement in Fatigue Scores for Primary Sjögren’s Patients Receiving a Tailored Multidisciplinary Fatigue Intervention in a Generic Fatigue Clinic | 2016 |
|
Ben Hargreaves Dr Dennis Lendrem Vicki Hindmarsh Claire Humphrey Sheryl Mitchell et al. | Assignable Causes for Fatigue in Primary Sjögren’s Syndrome: Data from the UK Primary Sjögren’s Syndrome Registry | 2015 |
|
Dr Arthur Pratt Ben Hargreaves Dr Dennis Lendrem Professor John Isaacs
| Components of treatment delay in rheumatoid arthritis differ according to autoantibody status | 2015 |
|
Dr Arthur Pratt Ben Hargreaves Christine Routledge Lesley Tiffin Julie Norris et al. | Reasons for Treatment Delay in Early Rheumatoid Arthritis Differ According to Autoantibody Status | 2015 |
|
Dr Arthur Pratt Dr Amy Anderson Dr Dennis Lendrem Julie Diboll Ben Hargreaves et al. | STAT3-regulated gene expression in circulating CD4+ T cells discriminates RA patients independently of clinical parameters in early arthritis: a validation study. | 2015 |
|
Dr Arthur Pratt Dr Amy Anderson Julie Diboll Andrew Skelton Ben Hargreaves et al. | The Importance of IL-6-STAT3 Mediated Activation of Circulating CD4+ T Cells in the Pathogenesis of Early Seronegative Rheumatoid Arthritis: A Validation Study | 2015 |
|
Sophie Noblett Dr Arthur Pratt Ben Hargreaves Christine Routledge Phil Mawson et al. | IL-6 Driven Stat3 Phophorylation in Circulating Lymphocytes is Specifiv for CD4+ T Cells in Early Rheumatoid Arthritis | 2014 |
|
Dr Amy Anderson Dr Arthur Pratt Ben Hargreaves Philip Brown Professor John Isaacs et al. | Phospho-STAT1/3 and Gene Expression Measurement in Circulating CD4+ T Cells As Diagnostic Tools in Early Autoantibody-Negative Rheumatoid Arthritis | 2014 |
|
Dr Amy Anderson Dr Arthur Pratt Ben Hargreaves Philip Brown Professor John Isaacs et al. | Phospho-STAT1/3 measurement in circulating CD4+T-cells as a diagnostic tool in early autoantibody-negative rheumatoid arthritis | 2014 |
|